Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Siegfried R. Erb"'
Autor:
Julie Zhu, Fatema Al-Alkim, Trana Hussaini, Alexandra Vertinsky, Danielle Byrne, Siegfried R. Erb, A. Jon Stoessl, Eric M. Yoshida
Publikováno v:
Annals of Hepatology, Vol 18, Iss 4, Pp 651-654 (2019)
Rapid overcorrection of chronic hyponatremia can lead to osmotic demyelination syndrome or central pontine myelinolysis (CPM), a diagnosis often triggered by observing the characteristics of neurological abnormalities developed as a result of CPM. Ho
Externí odkaz:
https://doaj.org/article/c04533f343de4928a1604afe2e8accc2
Autor:
Ip Stephen, Trana Hussaini, Aliya Daulat, Nilufar Partovi, Siegfried R. Erb, Eric M. Yoshida, Vladimir Marquez
Publikováno v:
Annals of Hepatology, Vol 16, Iss 2, Pp 230-235 (2017)
Background. Chronic renal failure (CRF) is a significant cause of morbidity and mortality in post-liver transplantation (LT) recipients. The risk factors associated with the development of renal dysfunction are not clearly elucidated. Objectives. To
Externí odkaz:
https://doaj.org/article/a80a83fb6e054364ac6c909492fc9103
Autor:
Ramesh Saeedi, Ali Mojebi-Mogharar, Supna K. Sandhu, Joshua A. Dubland, Jo-Ann Ford, Masoud Yousefi, Morris Pudek, Daniel T. Holmes, Siegfried R. Erb, Wing C. Peter Kwan, David L Kendler, Eric M. Yoshida
Publikováno v:
Annals of Hepatology, Vol 16, Iss 2, Pp 207-214 (2017)
Background. Patients with chronic hepatitis B virus (HBV) are often treated with nucleoside/nucleotide antiviral agents and metabolic bone toxicity is a possible concern.Objective. To determine the relationships between fibroblast growth factor 23 (F
Externí odkaz:
https://doaj.org/article/bb7188e7b0ef46db8d80447d6b84672a
Autor:
Trana Hussaini, PharmD, Eric M. Yoshida, MD, Nilu Partovi, PharmD, Siegfried R. Erb, MD, Charles Scudamore, MD, Stephen Chung, MD, Vladimir Marquez, MD
Publikováno v:
Transplantation Direct, Vol 5, Iss 3, p e429 (2019)
Background. Acute kidney injury (AKI) in the setting of liver transplantation is a common and multifaceted complication. Studies in the general population have demonstrated worse prognosis with AKI episodes that persist for a longer duration. Our pri
Externí odkaz:
https://doaj.org/article/a58c9272a6a647dd8067b1ce35b5d328
Autor:
Robert A. Mitchell, MD, Trana Hussaini, PharmD, Alan H. Yau, MD, Mel Krajden, MD, Alissa J. Wright, MD, Charles H. Scudamore, MD, Vladimir Marquez Azalgara, MDCM, Siegfried R. Erb, MD, Eric M. Yoshida, MD
Publikováno v:
Transplantation Direct, Vol 4, Iss 3, p e347 (2018)
Background. The goal of treating chronic hepatitis C virus (HCV) infection is sustained virologic response (SVR). There is concern that despite achieving SVR, replication-competent HCV may be sequestered at low levels within the liver and could theor
Externí odkaz:
https://doaj.org/article/08a86de1fb63407592f302228eafeca6
Autor:
Yangmin Zeng, Alex Magil, Trana Hussaini, C. Kit Yeung, Siegfried R. Erb, Vladimir Marquez-Alazagara, Eric M. Yoshida, MD, MHSc, FRCP(C), FACP, FACG, FCAHS, FAASLD
Publikováno v:
Annals of Hepatology, Vol 14, Iss 1, Pp 137-140 (2015)
Renal dysfunction frequently occurs in liver transplant recipients and is associated with increased morbidity and mortality. BK virus is a human polyoma virus that reactivates during immunocompromised states and is a known cause of renal allograft dy
Externí odkaz:
https://doaj.org/article/474eb5a606c54b58ae071e9b24f03a14
Autor:
Nawal Al Nahdi, Jo-Ann Ford, Erica D. Greanya, Jo-Ann Harrigan, Irene Tse, Urs P. Steinbrecher, Siegfried R. Erb, Eric M. Yoshida
Publikováno v:
Annals of Hepatology, Vol 12, Iss 1, Pp 156-160 (2013)
Fibrosing cholestatic hepatitis (FCH) is a less common but well-recognized severe complication of recurrent hepatitis C virus (HCV) infection post-liver transplant. This condition is fatal without successful treatment and to date; post-transplant ant
Externí odkaz:
https://doaj.org/article/088149d622904119bc462fe8bd5f866e
Autor:
Anna Maruyama, Trana Hussaini, Nilufar Partovi, Siegfried R. Erb, Vladimir Marquez Azalgara, Nadia Zalunardo, Neora Pick, Mark Hull, Eric M. Yoshida
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 2016 (2016)
Although major advances have occurred in treating patients with hepatitis C virus (HCV) with the development of new direct-acting antivirals (DAAs), treatment of liver transplant recipients with HCV, human immunodeficiency virus (HIV) coinfection, an
Externí odkaz:
https://doaj.org/article/f38d6d8edd744d8cb88ea7c6e2b6502a
Autor:
Ananta Gurung, Eric M. Yoshida, Charles H. Scudamore, Almoutaz Hashim, Siegfried R. Erb, Douglas L. Webber
Publikováno v:
Annals of Hepatology, Vol 11, Iss 5, Pp 715-720 (2012)
Primary hepatic neuroendocrine tumours are rare tumours effecting relatively young patients. As metastatic neuroendocrine tumours to the liver are much more common, extensive investigations are crucial to exclude a primary tumour elsewhere. We report
Externí odkaz:
https://doaj.org/article/ce81832f512a40c885df17ae366d6db6
Publikováno v:
Annals of Hepatology, Vol 13, Iss 5, Pp 565-567 (2014)
Pegylated interferon alpha (PEG-IFN α), a key component of chronic hepatitis C therapy, has been linked to the development of auto-antibodies and autoimmune disease. We report the first case of antimitochondrial antibody (AMA) seroconversion during
Externí odkaz:
https://doaj.org/article/51697dcacb124825b730244b46ce601c